Page 111 - GPD-2-1
P. 111

Gene & Protein in Disease                                          Autoimmune thyroid disease in narcolepsy



            limbs, causing her to fall down, but would be relieved after   the patient’s normal thyroid function, no treatment was
            a few seconds; she also experienced sleep fragmentation   administered. Only modafinil was prescribed to improve
            at night with excessive dreams. At the same time, she was   the patient’s sleep symptoms. After a year of follow-up,
            surprised to find that her body weight had increased by   the  patient’s  sleep  symptoms  and  thyroid  function  were
            approximately 25 kg within a year. A standard neurological   re-evaluated. We found a significant improvement in the
            examination and a neuropsychological assessment of   patient’s  EDS;  however,  she  developed  hypothyroidism.
            the patient were performed by a neurologist. She scored   Otherwise, there was also significant improvement in her
            18  points on the epworth sleepiness scale, which was   cataplexy attacks. Following a discussion with the patient
            used to assess the degree of subjective sleepiness , and   and her family members, the patient was started on thyroid
                                                     [9]
            12 points on the Pittsburgh Sleep Quality Index, suggesting   replacement therapy so as to achieve a euthyroid state,
            average sleep quality. The magnetic resonance imaging and   while still receiving modafinil.
            magnetic resonance angiography of her brain were normal.   The research protocol of this study was approved by the
            She was otherwise well with no significant comorbidity or   Research Ethics Committee of Henan Provincial People’s
            family history of neurological illness. Given  these clues,   Hospital, and the participant signed the written informed
            polysomnography (PSG) and multiple sleep latency test   consent forms.
            (MSLT) were performed on the patient to further clarify
            the diagnosis. PSG study showed a total sleep time of   3. Discussion
            579.5 min, sleep efficiency of 76.5%, and apnea-hypopnea
            index of 1.7/h, which can exclude obstructive sleep apnea   The previous studies have found that the prevalence rate
            (Table 1). Her MSLT showed a mean sleep latency of   of immunopathological diseases is higher in patients
            0.7 min and four sleep-onset rapid eye movement periods   with narcolepsy [8,10,11] . Cataplexy, in particular, is often
            (SOREMPs) in five naps without notable sleep paralysis.   associated with comorbid immunopathological diseases
                                                                                    [8]
            Her cerebrospinal fluid hypocretin-1, measured by   associated with narcolepsy . However, to the best of our
            enzyme-linked  immunosorbent  assay,  was  71.54  pg/mL.   knowledge, this is the first case of narcolepsy with AITD.
            In addition, she was found to be HLA-DQB*06:02 positive.   According to the ICSD-3 diagnostic criteria for narcolepsy,
            According  to the International Classification of  Sleep   this case was not difficult to diagnose. In addition, the
            Disorders, 3  edition (ICSD-3), we diagnosed the case as   previous studies have also demonstrated that weight
                      rd
            narcolepsy Type 1 (NT1).                           gain,  in particular, is  often  related  to  narcolepsy  with
                                                               cataplexy [12-14] . Impaired feeding behavior, including binge
              Laboratory tests for the patient, including complete   eating, nocturnal eating, and increased food cravings, may
            blood count, renal function, electrolytes, cardiac enzymes,   contribute to this phenomenon . In addition, abnormal
                                                                                        [15]
            liver enzymes, sex hormones, fasting growth hormone,   energy metabolism and reduced spontaneous activity are
            autoimmune encephalitis antibody, immunoglobulin, and   also important factors that contribute to the altered body
            complement tests, were all normal. However, her serum   mass index .
                                                                        [16]
            25-hydroxyvitamin D (25(OH)D) level was 12.45 ng/mL
            (normal range >20 ng/mL), and her thyroid function test   AITD is characterized by the dysfunction of thyroid
                                                                                                           [17]
            showed abnormally high levels of thyroglobulin antibody   tissue by antibody-mediated immune  inflammation .
            (TgAb) and thyroid peroxidase antibody (TPOAb)     TPOAb  and  TgAb  are  the  main  thyroid  autoantibodies
            (Table 2). Her thyroid gland was normal in texture and   that cause thyroid destruction and suppression of
            size. Following-up with the patient’s past medical history,   function. They are sensitive indicators for the diagnosis
                                                                                                    [18]
            the patient had not consumed any antithyroid drugs.   and prognosis of autoimmune thyroid disease . Elevated
            There was also no antecedent history of thyroidectomy,   levels of TPOAb and TgAb are early manifestations in
            neck  radiotherapy,  and  radioactive  iodine  ( I)  therapy   patients with Hashimoto’s thyroiditis (HT) and may have
                                                131
            for hyperthyroidism. Based on her medical history and   initiated certain pathophysiological changes in the thyroid
            laboratory tests, she was diagnosed with AITD. Given   gland, albeit the normal thyroid function occasionally.
            Table 1. Result of PSG

                    TST     AWN/h    WASO      SE    N1     N2     N3    REM       AI       PLMI        AHI
                    (min)             (%)     (%)    (%)    (%)   (%)    (%)     (event/h)  (event/h)  (event/h)
            Value   579.5    4.0      13.4    76.5   29.2   43.4  11.9   15.5      6.1       0.4        1.7
            PSG: Polysomnography; AHI: Apnea-hypopnea index; AI: Arousal index; AWN/h: Awakenings per hour; N1, N2, N3: Standard non-rapid eye
            movement sleep stages; PLMI: Periodic limb movement index; REM: Rapid eye movement sleep; REML: Rapid eye movement sleep latency; SE: Sleep
            efficiency; TST: Total sleep time; WASO: Wakefulness after sleep onset


            Volume 2 Issue 1 (2023)                         2                      https://doi.org/10.36922/gpd.v2i1.235
   106   107   108   109   110   111   112   113   114   115   116